MedPath

the Efficency and Safety of Stretta in GERD

Conditions
Radiofrequency Ablation
GERD
Interventions
Device: Stretta
Registration Number
NCT03574831
Lead Sponsor
Capital Medical University
Brief Summary

This study evaluated the efficency and safety of the endoscopic radiofrequency procedure(Stretta) in adult gastroesophageal patients.

Detailed Description

Gastro-esophageal reflux disease (GERD) is the most common outpatient diagnosis in gastroenterology and is associated with a significant burden on the healthcare system. Proton pump inhibitors (PPIs) are the mainstay of GERD treatment,howerver, some patients have an unsatisfactory response to high doses of PPIs, which remains a challenge. The Stretta procedure, a radiofrequency (RF) application to the lower esophageal sphincter (LES), was introduced about 15 years ago as an alternative to chronic medical therapy or surgical intervention for GERD.The Stretta procedure appears to result in thickening of the LES, decreased transient LES relaxation rate and reduced esophageal acid exposure.The majority studies of Stretta were held in USA and Europe, the sduty of Stretta in Asia is rare. The investigators propose to perform a prospectively observiton study to evaluate the efficency of the Stretta procedure in patients of refractory GERD in China.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
  1. Age > 18 years
  2. Small hiatus hernia (< 2-3 cm)
  3. Los Angeles Grade 'A' or 'B' Reflux Esophagitis or non erosive esophagitis
  4. LES pressure <15 mm Hg
  5. PPI dependent / refractory GERD
  6. abnormal 24h esophagus pH-impedance monitoring
Exclusion Criteria
  1. Age < 18 years
  2. Large hiatus hernia (> 3 cm)
  3. Los Angeles Grade 'C' or 'D' Reflux Esophagitis
  4. LES pressure > 15 mm Hg
  5. Underlying coagulation disorder
  6. Previous Esophageal or Gastric surgery
  7. Pregnant
  8. major esophagus motility disorder according to Chicago v3.0

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
StrettaStrettaRadio Frequency Ablation (RFA) using a Stretta device.
Primary Outcome Measures
NameTimeMethod
GERD-HRQL scores[Time Frame: Change from Baseline HRQL scores at 1 month;Change from Baseline HRQL scores at 2 months;Change from Baseline HRQL scores at 6 months;Change from Baseline HRQL scores at 1 year]

the improvement of GERD-HRQL scores after procedure.Scale ranges 0-50 points, the lower score means the better efficacy.

Secondary Outcome Measures
NameTimeMethod
Number of patients who report independence from Proton Pump Inhibitor (PPI) drug post Stretta procedureChange from Baseline number at 1 month;Change from Baseline number at 2 months;Change from Baseline number at 6 months;Change from Baseline number at 1 year]

Questionnaire will be provided to each participant to report no further requirement of PPI drug post procedure.

Demeester Score1 year

the change of Demeester scores after procedure. The lower, the better.

LES Pressure1 year

the change of LES pressure after procedure.The higher, the better.

Number of participants with treatment-related adverse events1 month

Number of participants with treatment-related adverse events

Trial Locations

Locations (1)

Gastroenterology department,Beijing Tong Ren Hospital, Capital Medical University.

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath